Quality of recovery after anesthesia is an important measure of the early postoperative health status of patients. The Quality of Recovery-15 (QoR-15) questionnaire is a self-rated questionnaire used to assess the quality of postoperative recovery. This study is aimed at translating and validating the Korean version of QoR-15 (QoR-15K). One hundred fifty patients were included in this study. We translated the original version of QoR-15 into QoR-15K and evaluated its validity, reliability, responsiveness, and clinical feasibility. QoR-15K showed acceptable criterion, structure, and construct validities. Reliability was verified using Cronbach’s α (0.856), standard error of measurement (10.78), split-half reliability (0.831), test-retest reliability ( ρ = 0.945 , P ≤ 0.001 ), and intraclass correlation test-retest ( ρ = 0.903 , P ≤ 0.001 ). These results represent an acceptable reliability. Responsiveness was verified using Cohen’s effect size (1.39), standardized response mean (1.03), and the correlation between QoR-15K score and duration of anesthesia ( ρ = − 0.197 , P = 0.016 ). These results show acceptable responsiveness. The mean ± standard deviation time to complete QoR-15K was 138.1 ± 30.7 s . QoR-15K was rated more than adequate on the COnsensus-based Standards for the selection of health Measurement INstruments checklist. In conclusion, QoR-15K shows acceptable validity, reliability, responsiveness, and clinical feasibility and may help evaluate postoperative quality of recovery in Korean populations.
Atypical facial pain (AFP) is a type of facial pain which does not fulfill any other diagnosis. It has several features such as no objective signs, no obvious explanation of the cause and poor response to treatments. We report a case of a female patient with AFP on the left maxillary area. The pain was increased by cold innocuous stimulation and thermography showed that the temperature on the painful area was significantly decreased. The pain was successfully alleviated by stellate ganglion block (SGB). Therefore, SGB can be effectively used to treat AFP.
Background:Propofol, an intravenous anesthetic, often causes pain on injection, which can be very distressful to patients. We investigated the analgesic effect of pregabalin on pain following propofol injection, compared with lidocaine.Methods:In a randomized, double-blind, prospective trial, 120 patients were randomized into 3 groups of 40 each; who received oral placebo and intravenous lidocaine 40 mg with venous occlusion for 1 minute (group L, n = 40), oral pregabalin 75 mg and intravenous normal saline with venous occlusion for 1 minute (group LP, n = 40), and oral pregabalin 150 mg and intravenous normal saline with venous occlusion for 1 minute (group HP, n = 40) as pretreatment, followed by administration of 1% propofol 0.5 mg/kg. Pain intensity was measured on a 4-point scale (0 = no, 1 = mild, 2 = moderate, and 3 = severe pain). Any side effects associated with pretreatment substances were recorded during the first 24 hours after surgery.Results:A total of 120 patients completed this trial. Demographic data were similar between groups. The incidence of pain following propofol injection was significantly reduced in group HP (50%) and group L (55%) compared with group LP (92.5%) (P < 0.05, respectively). The incidences of moderate pain in group HP (12.5%) and group L (15%) were significantly decreased compared with group LP (37.5%; both, P < 0.05). There were no significant differences in the incidence of side effects such as headache and dizziness between groups.Conclusion:Pretreatment with oral pregabalin 150 mg and intravenous lidocaine 40 mg with venous occlusion equally reduced pain from propofol injection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.